Q2 Earnings Today: Coforge, SBI Life, SBI Cards, Dr. Reddy’s Laboratories Results Preview

Q2 Earnings Today: Coforge, SBI Life, SBI Cards, Dr. Reddy's Laboratories Results Preview

Q2 Earnings Today: Top Companies to Watch

Dr. Reddy’s Laboratories Ltd., Coforge Ltd., SBI Life Insurance Company Ltd., and SBI Cards and Payments Services Ltd. are among the top names that will announce their quarterly results on Friday. In this article, we will delve into the earnings estimates of these companies and provide insights into what investors can expect from their Q2 results.

Dr. Reddy’s Laboratories Q2 Results Preview

Dr. Reddy’s Labs is projected to report an 8.6% growth in revenue for the second quarter of FY26. The company’s estimated topline is expected to be at Rs 8,706.17 crore, compared to Rs 8,016.2 crore in the year-ago period. Bloomberg analysts estimate the company’s bottom line to be up by 16.1% at Rs 1,397.47 crore from Rs 1,319.98 crore in the same quarter last year.

Earnings before interest, tax, depreciation, and amortisation (EBITDA) are projected to be around Rs 2,157.73 crore compared to Rs 2,245 crore. Whereas the margin is estimated at 24.8%. To know more about EBITDA margin and its significance, click here.

Coforge Q2 Results Preview

The IT giant’s consolidated bottom-line is estimated to be at Rs 360.75 crore against Rs 247.2 crore in the previous quarter, according to Bloomberg analysts. Coforge’s revenue is estimated to be at Rs 4098.59 crore against Rs 3688.6 crore. Earnings before interest and taxes are estimated to be around Rs 561 crore. The EBIT margin is estimated to be 13.68%.

To learn more about the IT sector in India and its growth prospects, click here. You can also visit our website to know more about how to invest in stocks and maximize your returns.

SBI Cards and Payments Services Q2 Results Preview

SBI Cards and Payments Services’ revenue is expected to see a marginal rise of 0.3% to Rs 4436.38 crore from Rs 4421.04 crore in the year-ago period. On the other hand, Bloomberg analysts estimate a robust rise of nearly 42% in the company’s Net Profit. The company is expected to report its bottom-line at Rs 572.46 crore against Rs 404.42 crore in the same quarter last year.

The net interest income is estimated to be at Rs 1734.94 crore, compared to Rs 1502.06 crore in the second quarter of FY25. To know more about net interest income and its impact on banking stocks, click here.

SBI Life Q2 Results Preview

Bloomberg analyst estimates SBI Life’s revenue to be at Rs 17,640.08 crore, while the net profit of the company will see a rise of nearly 7%, from Rs 529.42 crore in the year-ago period to Rs 565.75 crore for the current quarter.

To learn more about the insurance sector in India and its growth prospects, click here. You can also visit our website to know more about how to invest in insurance stocks and maximize your returns.

Conclusion

In conclusion, the Q2 results of these top companies will be closely watched by investors and analysts. The earnings estimates suggest that Dr. Reddy’s Laboratories, Coforge, SBI Cards and Payments Services, and SBI Life are expected to report strong revenue and profit growth. However, the actual results may vary depending on various factors such as market conditions, competition, and regulatory environment.

Investors should keep a close eye on the results and analyze the companies’ performance before making any investment decisions. To stay updated with the latest news and analysis, visit our website and follow us on social media. You can also learn more about stock market analysis and investment strategies to maximize your returns.

Sreenivasulu Malkari

πŸ’» Freelance Trading Tech Specialist | 15+ yrs in markets Expert in algo trading, automation & psychology-driven strategies πŸ“ˆ Empowering traders with smart, affordable tools

Leave a Comment